BeStock  
Stocks › Biotechnology › CRMD

CorMedix CRMD

US equityMarket cap rank #3659Biotechnology
$5.27 +$0.19 (+3.74%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $5.32 +0.95%
Open$4.96
Prev close$5.08
Day range$4.95 – $5.32
Volume3.61M
Market cap$419.16M
P/E (TTM)8.2
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$51.26M-50.8% YoY
Operating profit-$6.62M-112.9% YoY
Net profit-$14.72M-113.6% YoY
Diluted EPS-$0.19-115.1% YoY
Free cash flow$87.79M+189.2% YoY
Operating cash flow$89.70M

Revenue, last 8 quarters

$31.2MDec '24$39.1MMar '25$39.7MJun '25$104.3MSep '25$128.6MDec '25$127.4MMar '26$99.3MJun '26$51.3MSep '26

Net profit, last 8 quarters

$13.5MDec '24$20.6MMar '25$19.8MJun '25$108.6MSep '25$14.0MDec '25$38.6MMar '26$26.0MJun '26$-14.7MSep '26

Diluted EPS by quarter

0.22Dec '240.30Mar '250.28Jun '251.26Sep '250.16Dec '250.43Mar '260.29Jun '26-0.19Sep '26

Free cash flow by quarter

$-5.6MDec '24$19.7MMar '25$30.0MJun '25$30.4MSep '25$92.7MDec '25$41.7MMar '26$85.7MJun '26$87.8MSep '26

Annual revenue

$239.2KFY20$190.9KFY21$65.4KFY22$0.0FY23$43.5MFY24$311.7MFY25

Profitability & balance sheet

Gross margin77.0%
Operating margin39.4%
Net margin15.6%
Return on equity15.1%
Return on assets7.5%
Return on invested capital11.1%
Current ratio2.43
Liabilities / assets49.7%
Cash & investments$355.15M
Total debt$145.42M
Net cash (debt)$209.73M
Free cash flow / sales76.2%

Where the revenue comes from

Quarter 2026/Q2

By business line

  • DefenCath$66.12M 66.6%
  • Melinta Portfolio$28.22M 28.4%
  • Contract revenue$4.97M 5.0%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $54.52M – $127.43M $311.71M $128.62M
Total Operating Revenue $51.26M $99.31M $127.43M $311.71M $128.62M
Cost of Revenue $24.52M $24.81M $22.31M $35.96M $21.31M
Gross Profit $26.75M $74.50M $105.12M $275.75M $107.31M
Operating Expense $33.37M $31.59M $41.46M $125.61M $48.18M
Selling and Admin Expenses $29.59M $27.53M $34.25M $106.27M $39.58M
-Selling & Marketing Expense $11.68M $12.45M $12.53M $38.05M $16.01M
-General & Admin Expense $17.90M $15.09M $21.72M $68.22M $23.57M
Research & Development $7.04M $6.68M $7.21M $19.33M $8.60M
Other Operating Expenses -$3.26M -$2.62M – – –
Operating Profit -$6.62M $42.91M $63.66M $150.14M $59.13M
Other Income (Expense) -$9.83M -$4.18M -$8.01M -$1.19M -$3.74M
Gain on Sale of Security $1.18M $2.55M -$3.55M $5.31M $2.22M
Special Income (Charges) -$11.54M -$6.65M -$4.20M -$6.50M -$4.10M
-Less:Restructuring and Mergern & Acquisition $11.54M $6.65M $4.20M $6.50M $4.10M
Other Non-Operating Income (Expenses) $532,000.00 -$71,000.00 -$268,000.00 – –
Pretax Profit -$16.45M $38.73M $55.65M $150.02M $56.45M
Tax -$1.73M $12.75M $17.04M -$13.04M $42.43M
Net Profit -$14.72M $25.99M $38.60M $163.06M $14.02M
Profit from Continuing Operations -$14.72M $25.99M $38.60M $163.06M $14.02M
Net Income to Parent Company -$14.72M $25.99M $38.60M $163.06M $14.02M
Net Income to Common Stockholders -$14.72M $25.99M $38.36M $162.07M $13.03M
Basic EPS -$0.19 $0.33 $0.48 $2.25 $0.18
Diluted EPS -$0.19 $0.29 $0.43 $2.04 $0.16
Other Preferred Stock Dividends – – $241,000.00 $988,000.00 –
Net Non-Operating Interest Income (Expense) – – – $1.06M -$927,098.00
Non-Operating Interest Income – – – $3.85M $889,981.00
Non-Operating Interest Expense – – – $2.78M $1.82M

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $917.75M $904.05M $815.64M $826.14M $826.14M
Total Current Assets $502.99M $480.55M $383.11M $367.05M $367.05M
Cash and Cash Equivalents & Short-Term Investments $355.15M $256.69M $178.09M $148.53M $148.53M
-Cash and Cash Equivalents $355.15M $256.69M $178.09M $144.84M $144.84M
-Short Term Investments $0.00 $0.00 $0.00 $3.69M $3.69M
Receivables $76.71M $161.31M $154.81M $171.23M $171.23M
-Accounts Receivable $76.71M $161.31M $154.81M $171.23M $171.23M
Inventory $43.14M $38.58M $30.73M $29.72M $29.72M
Restricted Cash $656,000.00 $656,000.00 $656,000.00 $656,000.00 $656,000.00
Other Current Assets $27.34M $23.32M $18.83M $7.86M $7.86M
Total Non-Current Assets $414.75M $423.50M $432.52M $459.09M $459.09M
Net PPE $8.56M $7.85M $6.17M $8.98M $8.98M
-Gross PPE $8.56M $7.85M $6.17M $8.98M $8.98M
Goodwill and Other Intangible Assets $378.17M $388.47M $398.77M $409.07M $409.07M
-Goodwill $30.00M $30.00M $30.00M $30.00M $30.00M
-Other Intangible Assets $348.17M $358.47M $368.77M $379.07M $379.07M
Non-Current Deferred Assets $0.00 $0.00 $3.31M $16.28M $16.28M
Other Non-Current Assets $28.02M $27.17M $24.27M $423,000.00 $423,000.00
Total Liabilities $456.04M $443.22M $378.59M $420.84M $420.84M
Total Current Liabilities $207.29M $187.40M $128.78M $174.27M $174.27M
Payables $16.15M $23.29M $29.67M $21.45M $21.45M
-Accounts Payable $10.33M $10.24M $12.83M $7.88M $7.88M
-Total Tax Payable $5.82M $13.05M $16.84M $12.76M $12.76M
Current Accrued Expenses $159.76M $153.17M $91.30M $146.07M $146.07M
Other Current Liabilities $31.38M $10.94M $7.81M $5.31M $5.31M
Total Non-Current Liabilities $248.75M $255.82M $249.81M $246.57M $246.57M
Long Term Debt and Capital Lease Obligation $145.42M $145.15M $144.89M $147.47M $147.47M
-Long Term Debt $145.42M $145.15M $144.89M $144.63M $144.63M
Non-Current Deferred Liabilities $2.19M $663,000.00 – – –
Other Non-Current Liabilities $101.14M $110.01M $104.93M $99.10M $99.10M
Total Equity $461.71M $460.83M $437.05M $405.31M $405.31M
Stockholders' Equity $461.71M $460.83M $437.05M $405.31M $405.31M
Capital Stock $79,000.00 $78,000.00 $78,000.00 $79,000.00 $79,000.00
-Common Stock $79,000.00 $78,000.00 $78,000.00 $79,000.00 $79,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $588.33M $572.74M $574.94M $581.80M $581.80M
Retained Earnings -$126.71M -$111.99M -$137.97M -$176.58M -$176.58M
Gains/Losses Not Affecting Retained Earnings $2,000.00 $2,000.00 $2,000.00 $3,000.00 $3,000.00
Prepaid Assets – – – $9.05M $9.05M
Investments and Advances – – – $10.36M $10.36M
-Available for Sale Securities – – – $10.36M $10.36M
Non Current Accounts Receivables – – – $946,000.00 $946,000.00
Non-Current Prepaid Assets – – – $13.03M $13.03M
-Other Payable – – – $804,000.00 $804,000.00
Short-Term Debt and Capital Lease Obligation – – – $1.45M $1.45M
-Current Capital Lease Obligation – – – $1.45M $1.45M
-Long Term Capital Lease Obligation – – – $2.84M $2.84M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $89.70M $86.24M $42.38M $175.05M $94.46M
Net cash flow from continuing operations $89.70M $86.24M $42.38M $175.05M $94.46M
Net Income from Continuing Operations -$14.72M $25.99M $38.60M $163.06M $14.02M
Depreciation & Depletion & Amortization $10.53M $10.54M $10.54M $14.55M $10.43M
Deferred Tax $1.53M $3.98M $12.96M -$25.80M $33.89M
Other Non-Cash Items $11.93M $7.60M $4.65M $7.28M $4.33M
Change in Working Capital $77.69M $36.60M -$32.51M $7.33M $30.30M
-Change in Receivables $84.75M -$6.43M $16.45M -$90.92M -$12.40M
-Change in Inventory -$4.56M -$7.85M -$1.02M -$3.48M -$800,000.00
-Change in Prepaid Assets -$4.02M -$5.09M -$2.26M -$2.06M -$1.36M
-Change in Payables and Accrued Expense $1.53M $56.19M -$45.68M $104.10M $45.01M
Net cash flow from investing -$1.91M -$561,000.00 $2.97M -$308.43M $3.30M
Net Cash Flow from Continuing Investing Activities -$1.91M -$561,000.00 $2.97M -$308.43M $3.30M
Net PPE Purchase and Sale -$1.91M -$561,000.00 -$729,000.00 -$2.26M -$1.72M
Net Investment Purchase and Sale $0.00 $0.00 $3.69M $2.34M $3.53M
Financing Cash Flow $10.67M -$7.07M -$12.10M $238.45M -$1.41M
Net Cash Flow from Continuing Financing Activities $10.67M -$7.07M -$12.10M $238.45M -$1.41M
Net Common Stock Issuance $10.14M -$6.39M -$11.09M $90.16M $1.03M
Proceeds from Stock Option Exercised $1.79M $235,000.00 $1.18M $6.39M $3.59M
Net Other Financing Charges -$1.26M -$914,000.00 -$2.18M -$8.09M -$6.03M
Ending Cash Balance $356.14M $257.68M $179.08M $145.83M $145.83M
Net Change in Cash $98.46M $78.61M $33.25M $105.07M $96.35M
Beginning Cash Balance $257.68M $179.08M $145.83M $40.76M $49.48M
Effect of Exchange Rate Changes $0.00 $0.00 $0.00 $0.00 -$1,000.00
Free Cash Flow $87.79M $85.68M $41.65M $172.79M $92.74M
Gain/Loss from Continuing Operations – – – -$86,000.00 –
-Change in Other Current Liabilities – – – -$308,000.00 -$150,000.00
Net Business Purchase and Sale – – – -$308.51M $1.49M
Net Issuance Payments Of Debt – – – $150.00M $0.00

Discussion

No comments yet — be the first to weigh in on CRMD.

Sign in to join the discussion.

Scroll to Top